Deen D F, Hoshino T, Williams M E, Nomura K, Bartle P M
Cancer Res. 1979 Nov;39(11):4336-40.
The effects of spirohydantoin mustard (SHM), a potential antitumor agent for central nervous system tumors, in the in vitro 9L rat brain tumor model were studied. In cell culture medium at 37 degrees, the drug was totally detoxified within 30 min. Dose-response curves for exponentially growing and plateau-phase cells were similar and indicated that a small fraction of cells were resistant to SHM. When exponentially growing cells were treated with SHM (5 microgram/ml for 1 hr), recovery from potentially lethal damage occurred within 28 hr. When cells were perturbed by SHM, the S, G2, and M phases were prolonged, there was a G2 block, some cells entered mitosis, but few divided, and cells tended to accumulate in mid-S, then moved synchronously to G2-M. The rate at which cells moved was concentration dependent and was much slower at high concentrations. The ability of SHM to both synchronize cells and block DNA synthesis may be useful in multiagent therapy regimens.
研究了螺海因妥英氮芥(SHM),一种潜在的中枢神经系统肿瘤抗肿瘤药物,在体外9L大鼠脑肿瘤模型中的作用。在37摄氏度的细胞培养基中,该药物在30分钟内完全解毒。指数生长期和平稳期细胞的剂量反应曲线相似,表明一小部分细胞对SHM具有抗性。当指数生长期细胞用SHM(5微克/毫升,处理1小时)处理时,在28小时内发生了潜在致死损伤的恢复。当细胞受到SHM干扰时,S期、G2期和M期延长,出现G2期阻滞,一些细胞进入有丝分裂,但很少分裂,细胞倾向于在S期中期积累,然后同步移动到G2-M期。细胞移动的速率是浓度依赖性的,在高浓度下要慢得多。SHM同步细胞和阻断DNA合成的能力可能在多药治疗方案中有用。